Back | Next |
home / stock / alxn / alxn message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: 7% 3.5M C3.14 WL Vol increasing biotech hot. | znewcar1 | investorshangout | 07/13/2018 8:30:18 PM |
ALXN buy 129.83 | stocktrademan | investorshub | 03/16/2018 4:22:00 PM |
** PENDING BUYOUT! LOAD UP FOLKS!!!! | Inthe203 | investorshub | 09/14/2017 3:38:48 AM |
ALEXION TRIMMING THE FAT | Inthe203 | investorshub | 09/12/2017 5:23:41 AM |
Is the pipeline rich? | Pony up | investorshub | 08/07/2017 8:03:09 PM |
Apparently, Soliris drug sales are increasing. But.. | raff | investorshub | 07/27/2017 6:35:28 PM |
LAYOFFS ARE LOOMING! | Inthe203 | investorshub | 07/20/2017 1:19:29 AM |
CASH IN WHILE IT'S ON A HIGH! | Inthe203 | investorshub | 06/15/2017 1:49:02 AM |
On the up n up! | Mdragonpkf | investorshub | 06/11/2017 2:01:46 PM |
good ill buy more | cashmoneykid77 | investorshub | 06/08/2017 7:02:50 AM |
OH WAIT UNTIL NEXT WEEK FOLKS! | Inthe203 | investorshub | 06/08/2017 12:32:14 AM |
Up up and away hey, starting next week | Mdragonpkf | investorshub | 06/04/2017 1:10:54 AM |
LOL! Delusional. You're all in for a rude awakening. | Inthe203 | investorshub | 06/02/2017 11:37:36 PM |
Honestly all that I care about is the | cashmoneykid77 | investorshub | 06/02/2017 4:35:27 PM |
I thought message boards were here to share | Dr_Thorfin | investorshub | 05/30/2017 6:50:43 PM |
Sure, whatever makes you sleep at night. | Inthe203 | investorshub | 05/30/2017 6:05:36 PM |
LOL most people online claiming to live in $4m | Dr_Thorfin | investorshub | 05/30/2017 4:50:10 PM |
I will mortgage my home and bet 4M | Inthe203 | investorshub | 05/30/2017 3:39:36 PM |
Quote- I have never seen the clinical responses | Dr_Thorfin | investorshub | 05/30/2017 5:47:59 AM |
That's far fetched and will not happen. | Inthe203 | investorshub | 05/30/2017 2:31:23 AM |
News, Short Squeeze, Breakout and More Instantly...
Alexion Pharmaceuticals Inc. Company Name:
ALXN Stock Symbol:
NASDAQ Market:
Alexion Pharmaceuticals Inc. Website:
AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN) . The only hurdle left to jump is obtaining approval from United Kingdom regulators. In this Motley Fool Live video recorded on July 7 , Motley Fool contri...
This week, pharma and biotech giant AstraZeneca (NASDAQ: AZN) cleared its final hurdle in the proposed acquisition of orphan drug pharma company Alexion Pharmaceuticals (NASDAQ: ALXN) when it announced that the deal had received clearance from the United Kingdom's Compet...